TECHNOLOGY
TECHNOLOGY - B
SEEING THE HEART WITH ULTRASOUND:
THE REVOLUTION GOES ON!
J.R.T.C. Roelandt*, MD, FACC; N. Bruining, MD, and N. Bom, MD Thoraxcentre, Department of Cardiology, Erasmus MC,
Rotterdam, the Netherlands
Table 1: Cardiac
Ultrasound
Table 2: THREE-DIMENSIONAL ECHOCARDIOGRAPHY
Table 3: Three-dimensional
echocardiography
Table 4: THE ULTRASOUND STETHOSCOPE
Table 5: The ultrasound
stethoscope
Observation and serendipity together
with changes in clinical objectives and
advances in computer technology have resulted in a variety of amazing cardiac imaging technologies using many different energy forms: X-rays, ultrasound, radioactivity and magnetic resonance. Cardiac ultrasound represents the most important breakthrough for widespread imaging since the introduction of X-rays at the end of the 19th century and its development has closely paralleled advances in computer technology.
Currently available ultrasound
Evolutionary advances |
|
Transthoracic M-mode and two-dimensional echocardiography
Transesophageal echocardiography
Doppler (pulsed-wave and continuous-wave)
Colour flow imaging
Epicardial echocardiography
Contrast echocardiography
Stress echocardiography
Acoustic quantification/color kinesis
Tissue harmonic imaging
Tissue Doppler imaging
Therapeutic ultrasound
|
Revolutionary advances |
|
Intracardiac/intracoronary echocardiography*
Three-dimensional echocardiography
Small personal imager (ultrasound stethoscope)
|
*These invasive imaging procedures will not be discussed
systems provide a high imaging
performance with an increasing number of modalities
allowing a comprehensive assessment of cardiac
structure function and hemodynamics with unprecedented
versatility (table 1).
The method is now being used to image the heart
at any age from the fetus to the very old and
in any situation from mobile services to intraoperative.
A definitive diagnosis and quantitative assessment
of most cardiac conditions can now be made and
minimizing the need for further work-up by invasive
testing in many patients. Consequently, cardiac
ultrasound has revolutionized the practice of
cardiology.
Recently, microprocessor techniques and miniaturization
have led to revolutionary advances in cardiac
ultrasound which will have a further impact on
both its diagnostic potential and its use in clinical
practice. Portable lightweight battery-powered
systems represent the one end of the spectrum
of these developments and these devices can be
used just like a standard stethoscope as part
of the physical examination at the place-of-care.
Real-time three-dimensional echocardiography represents
the other end and allows capturing a series of
three-dimensional data sets within one cardiac
beat.
In this paper we will briefly review the innovative
revolutionary developments and their future impact
on clinical cardiology.
Multidimensional anatomy is mentally
reassembled from sequential tomographic views.
This is a difficult process for complex cardiac
structures and pathology of unknown morphology.
Computer technology has resulted in presenting
three-dimensional depictions of cardiac anatomy
as well as physiology by reorganisation of multiple
spatially related cross-sectional images into
a volumetric dataset. Over the years, several
directions have been followed in three-dimensional
echocardiography.1
Undoubtedly, the most challenging is real-time
three-dimensional echocardiography.This method,
developed by Von Ramm et al of Duke University,
is based on novel matrix phased-array transducer
technology and using parallel processing techniques
allows to scan a pyramidal volume at once. Real-time
three-dimensional echocardiography will find a
major application for global ventricular and regional
wall function in stress echocardiography and for
myocardial perfusion studies using echo contrast
agents. With improving image quality, real-time
three-dimensional echocardiography will eventually
become the standard echocardiographic examination
procedure.
At present, most experience with three-dimensional
echocardiography is with software controlled mechanical
acquisition of a consecutive series of cardiac
cross-sectional images using currently available
standard transducers and computer assisted “off-line”
three-dimensional reconstruction. This approach
necessitates the simultaneous registration of
the accurate spatial position and timing of the
cross-sectional images. Positional information
can be obtained with acoustic (spark gap) or magnetic
location systems allowing unrestricted (free-hand)
scanning from any available precordial acoustic
window. Surface rendered or wire-frame reconstructions
of selected structures are generated from manually
or automatically derived contours in the cross-sectional
images. This approach allows improved quantification
of left ventricular volumes and mass but provides
limited structure information.
Scanning techniques using a predetermined
geometric acquisition pattern (linear, fan-like
and rotational which is the most commonly used)
allow for the recording of closely and evenly
spaced cross-sectional images. The rotational
acquisition has practical advantages and is performed
with either multiplane transesophageal probes
or precordial probe assemblies accommodating standard
transducers interfaced to standard echocardiographic
equipment.3,4 Image acquisition is controlled
by a software-based steering logic which considers
both cardiac and respiratory cycle variation.
Volume rendering algorithms are applied and provide
grey-scale tissue information in the reconstructions
representing a significant advance over surface
rendered reconstructions.
Recently, an ultrafast continuously rotating
phased-array transducer which allows the acquisition
of 16 volumetric data sets per second has been
developed at the Thoraxcentre.5 Standard imaging
processing equipment is used for reconstruction
and analysis. This “near real-time” or ultrafast
approach may become an alternative to real-time
volumetric imaging systems in specific clinical
conditions and for global and regional myocardial
function analysis.
Figure 1
|
Figure 1 . Three-dimensional images of
aortic valves viewed from above. The upper
panels show an electronically extracted
image of a normal valve in systole and diastole.
The tricuspid valve and the coaptation lines
are clearly seen in the diastolic image.
The middle panels show a stenotic aortic
valve. The valve cusps are thickened and
there is incomplete opening with a small
stenotic orifice in systole. The lower panels
show three-dimensional volume rendered images
of a bicuspid aortic valve (surgical view).
The mouth-like orifice can be appreciated
in a single projection and the raphe is
seen both in systole and diastole (arrow).
|
With currently available technology,
details of cardiac anatomy and pathology are already
well appreciated. “En face” views of cardiac structures
are unique for three-dimensional echocardiography.
They have been proven valuable in valvular 6,7
and congenital heart disease8-10 by providing
a dynamic view of pathology and better insights
into what will be found during the surgical procedure
(figures 1-2). This information is already of
particular help in reconstructive surgery of mitral
valve, for repair of congenital heart defects
and device closure of an atrial septal defect11
(table 2).
Figure 2
CURRENT
CLINICAL APPLICATIONS
|
|
Congenital heart disease
ASD device closure
Mitral valve prolapse and repair
Global LV function and mass
|
The greatest advantage at present,
however, is the possibility of accurate quantitative
measurements. The need for making geometric
assumptions to calculate ventricular volumes
is eliminated by the use of a series of computer
generated cross-sections rather than one or
two orthogonal planes.12-18 Parallel slicing
from base to apex through the data set results
in equidistant cross-sections at a selected
interval (paraplane echocardiography) (figure
3). Technology for automated border detection
is already available in order to calculate the
surface area of these cross-sections. The endocardial
contours of a sequence of images obtained with
a multiplane (omniplane) precordial transducer
can be directly analysed and used for volume
calculation without going through the reconstruction
process (figure 4). Both methods permit the
accurate measurement of cardiac chamber volumes,
LV mass and other structures such as e.g. mass
lesions. Currently, analytic software to measure
the regurgitant jet volume from color Doppler
flow images is being developed. Clearly, all
these possibilities will allow examination of
new quantitative parameters which are uniquely
three-dimensional (e.g. curvature analysis and
wall stress) and will expand the range of clinical
questions that can be addressed together with
a number of problems solved for improved patient
management (table 3).
Advantages
|
|
Decreases interpretation variability
Electronic cardiotomy and ‘en face’ views
Quantitation of (complex) volumes
New parameters (e.g. shape analysis)
Off-line (re) examination
Teleconsultation and tele-examination
Virtual reality
|
Published experience with three-dimensional
echocardiography indicates that the basis has
been laid for the next phase in the revolution
of cardiac ultrasound and that with further
refinements the method will become the ultimate
diagnostic imaging modality in daily practice.
The availability of data-sets
containing all cardiac data offers unique advantages.
The display and analysis of size, shape and
motion of cardiac structures from any desired
perspective becomes possible and allows one
to address any clinical question off-line without
re-examination of the patient. Unique cardiac
cross-sections, difficult or impossible to obtain
from standard acoustic windows, can be computed
from the data set in any desired plane (anyplane
echocardiography) and displayed in cine-loop
format. Regions of interest can be extracted
from the data set and structures of interest
removed from their surroundings for detailed
analysis.
In the future, the examination
procedure will be less dependent on the skill
and experience of the operator as the echocardiographic
examinations will be performed with computer
controlled transducer systems and standardised
for specific cardiac conditions.
Figure 3
|
Figure 3. The priciple of left ventricular
volume measurement using Simpson’s rule
using three-dimensional echocardiography.
An end-diastolic long-axis vies (left
upper panel) is selected as a reference
image from the three-dimensional echocardiographic
dataset. The left ventricle is automatically
sliced by the paraplane method into eight
equidistant parallel short-axis slices
spanning the left ventricular cavity from
the apex to mitral annulus. The endocardial
border of the left ventricle is traced
manually in each of short-axis slices
1-8 (right panel).
|
Recently, virtual reality has
been integrated with cardiac three-dimensional
echocardiography. A virtual reality heart model
linked to a volumetric data set provides the
observer spatial information in difficult cardiac
conditions when integrated with the 3-D reconstruction
software.18 Since visualisation of cardiac pathology
can be realised from an infinite number of viewpoints,
these reconstructions can pose interpretation
difficulties for other observers in understanding
both the origin and orientation of selected
views.
This phenomenon is also referred
to as “lost in space” effect. Standardized echocardiographic
views can be selected with the virtual reality
heart model and can be used as an orientation
tool in diagnostic studies and for teaching
purposes. Virtual reality is the initial step
to automatic 3-D computations with minimal operator
interaction. Further developments will include
higher dimensional imaging showing phenomena,
which are normally invisible in the three-dimensional
world. Propagation of the electrical activation
of the heart is an example and the computer
can create a visual image from this nonvisual
information, which only remotely resembles the
original structure.
Miniaturisation and digital
techniques have resulted in the development
of high resolution battery-powered personal
imaging devices with excellent grey-scale and
colour blood flow imaging capabilities (figure
5). These devices are practical to use and allows
visualization of the heart and its pathology
during the physical examination and to address
specific clinical problems anywhere at the point
of care.19,20
Figure 4
|
Figure 4. Left ventricular volume measurement
using a three-dimensional dataset from
which a series of eight long-axis views
are used. The left panel is a computer-generated
short-axis view and serves as a reference
view. The surface area of each cross-section
is measured and the volume calculated.
|
|
Figure 5
|
Figure 5. Photographs of the (A) MinivisorTM
developed in 1978.32-34 and currently
available hand-held ultrasound devices
(B) OptiGoTM, (C) SonoHeartTM and (D)
TerasonTM.
|
They are approximately named
“ultrasound stethoscopes” since they allow to
look inside the chest (stethos = chest and skopein
= see). These small personal ultrasound devices
should not be confused with the portable desk-top
systems which are full featured systems. The
ultrasound stethoscope extends the perception
of a physical examination by direct “visualising
the invisible pathology” and provides information
beyond what we can perceive with palpation and
auscultation. Murmurs and abnormal precordial
movements can be directly related to cardiac
structural, functional and flow abnormalities
(figures 6 and 7). A cardiac abnormality (pericardial
effusion, dilated heart, valvular disease, mass
lesion) is rapidly confirmed during a routine
physical examination (table 4). Often a specific
diagnosis is made and incidental and unexpected
findings are regularly recognised.
Table
4: THE ULTRASOUND STETHOSCOPE
|
|
Part
of physical examination anytime, anywhere:
Rapid clinical diagnosis
Source of murmurs
Dilated heart
Pericardial effusion, emergent tamponade
Pulmonary embolus
Valvular disease
Mass lesion
Wall function
Dilatation abdominal aort/aneurysm
|
A major strength is that a
limited echo/color Doppler examination may allow
exclusion of cardiac abnormality with great
certainty after limited training. Overall, the
use of these devices will strengthen our physical
diagnostic accuracy and will add quantitative
information.
Figure 6
|
Figure 6. Apical four chamber view of
a 25-years-old-female with systemic lupus
erythematosus and shortness of breath.
The referral diagnosis was: pericarditis?
The patient has regurgitant jets of aortic
regurgitant (A) and mitral regurgitation
(B), but no pericarditis (OptiGoTM).
|
|
Figure 7
|
Figure 7. Apical four chamber view of
a 45-years-old male with dilated cardiomyopathy.
(A) A mitral regurgitant jet is visualised
(SonoHeartTM). (B) The imaging quality
of the hand-held device can be appreciated
against that of a standard echocardiographic
system (HP, Sonos 5000TM).
|
A major strength is that a
limited echo/color Doppler examination may allow
exclusion of cardiac abnormality with great
certainty after limited training. Overall, the
use of these devices will strengthen our physical
diagnostic accuracy and will add quantitative
information.
The diagnosis and follow-up
of many cardiac conditions requires only a fraction
of the potential of the high-end ultrasound
systems and a specific clinical question can
often be answered within little time and with
little examination protocols. The ultrasound
stethoscope is suitable for such a limited “goal-oriented
examination” (e.g. resolution of pericardial
effusion after pericardicentesis, left ventricular
function, left ventricular hypertrophy). These
devices can effectively assist in the initial
evaluation and rapid diagnosis of potentially
life threatening conditions or in situations
where quick decision-making is essential (emergent
tamponade, low output states, acute valvular
pathology, right ventricular involvement and
mechanical complications of acute myocardial
infarction).21,22
Better indications and more
targeted referral for expensive imaging technologies
may lead to significant cost savings. Detection
or exclusion of regional wall motion abnormalities
is a potential that can be utilised in patients
with acute chest pain and a non-diagnostic electrocardiogram.
Right ventricular involvement in acute myocardial
infarction and the mechanical complications
are readily diagnosed in the intensive care
unit.
The ultrasound stethoscope
allows rapid screening for a dilated aorta or
occult aortic abdominal aneurysm in patients
at risk,23,24 for left ventricular hypertrophy
in patients with hypertension,25 early heart
failure (asymptomatic LV dysfunction, less than
50% collapse of the inferior vena cava) (figure
8),26 mitral valve prolapse 27 and dilated aorta
(Marfan’s disease).
Obviously, a small ultrasound
imager cannot substitute for the high-end ultrasound
systems but there is no doubt, however, that
these devices will revolutionize the physical
cardiac examination (table 5). Their use involves
compromises some of which are still unknown
and will be learned when applications are expanding.
Training may become an important issue and should
focus on criteria of normalcy and the identification
of specific and major cardiac disorders. In
the future, advances in communications and software
will allow for diagnostic support from experienced
laboratories and help to solve training issues.
Three-dimensional echocardiography
provides the clinician with more confidence
for the diagnosis of cardiac disease and adds
insights to the understanding of complex pathology.
The availability of a three-dimensional data-set
allowsthe cardiologist to retrieve an infinite
number of different views after the examination
procedure providing accurate quantitative data
together with new functional parameters. Additional
information will allow to address new clinical
questions. For these reasons, three-dimensional
echocardiography will become an essential part
of the practice of cardiology. Research must
be directed towards identifying those cardiac
conditions in which the diagnostic potential
of three-dimensional echocardiography is superior
or more cost-effective than other imaging methods.
Figure 8
|
Figure 8. Imaging of the inferior vena
cava (IVC) through the liver during expiration
(A) and inspiration (B). The caliper function
allows measurement of the IVC dimension
during expiration (2.6 cm) and during
inspiration (1.9 cm). A collapse of less
than 50% indicates an elevated right-sided
filling pressure37 (OptiGoTM).
|
Table
5: The ultrasound stethoscope
|
|
Seeing the invisible
during the physical examination provides:
Higher diagnostic specificity and
sensitivity
Early (preclinical) diagnosis
Functional assessment
Blood flow information
Inferior vena cava collapse
Quantitative information
Abdominal aorta measurement
|
the cardiologist to retrieve
an infinite number of different views after
the examination procedure providing accurate
quantitative data together with new functional
parameters. Additional information will allow
to address new clinical questions. For these
reasons, three-dimensional echocardiography
will become an essential part of the practice
of cardiology. Research must be directed towards
identifying those cardiac conditions in which
the diagnostic potential of three-dimensional
echocardiography is superior or more cost-effective
than other imaging methods.
Small personal imagers will
undoubtedly become part of the cardiologist’s
paraphernalia. Extending our physical senses
with seeing the “invisible” cardiac pathology
will strengthen our diagnostic accuracy, allow
to address specific clinical problems anytime,
anywhere leading to a more rapid referral and
a more cost-effective use of expensive imaging
technologies. Many small devices, even of pocket
size, are now being developed and the “echocardiograph
in your pocket” will undoubtedly revolutionize
the physical cardiac examination and diagnosis.
It should be remembered, however,
that the real value of these revolutionary technologies
is intimately dependent on our intellectual
contribution to realize their optimal clinical
impact.
1. Roelandt J (ed). Three-dimensional echocardiography of the
heart and
coronary arteries.Van Zuiden
Communications B.V., Alphen a.d. Rijn, 1999.
2. Von Ramm PT, Smith SW. Real time volumetric ultrasound
imaging system.
J Digit Imaging1990;3:261- 6.
3. Roelandt JRTC, Ten Cate FJ, Vletter WB, Taams MA.
Ultrasounic dynamic three-dimensional visualization of the heart with
a
multiplane transesophageal imaging transducer
J Am Soc Echocardiogr
1994;7:217-29.
4. Roelandt J, Salustri A, Mumm B, Vletter W.
Precordial
three-dimensional echocardiography with a
rotational imaging probe: methods and
initial clinical experience.
Echocardiography 1995;12:243-52.
5. De Jong N, Lancee CT, Roelandt JRTC
Ultrafast data
acquisition for three-dimensional echocardiography
In Roelandt J (ed).
Three-dimensional echocardiography of the heart
andcoronary arteries. Van
Zuiden CommunicationsB.V., Alphen a.d. Rijn, 1999:p51-57.
6. Salustri A, Becker AE, Van Herwerden L, Vletter WB, Ten
Cate FJ,
Roelandt JRTC. Three-dimensional echocardiography of normal and
pathologic
mitral valve: a comparison with two-dimensional transesophageal
echocardiography.
J Am Coll Cardiol 1996;27:1502-10.
7. Cheng TO, Xie MX, Wang XF, Li ZA, Hu G.
Evaluation of
mitral valve prolapse by four-dimensional echocardiography.
Am Heart J 1997;133:120-9.
8. Salustri A, Spitaels S, McGhie J, Vletter W, Roelandt
JRTC.
Transthoracic three-dimensional echocardiography in adult patients with
congenital heart disease. J Am Coll Cardiol 1995;26:759-67.
9. Vogel M, Ho SY, Lincoln C, Yacoub MH, Anderson RH.
Three-dimensional echocardiography can simulate intraoperative visualization
of
congenitally malformed heart. Ann Thoracic Surg 1995;60:1282-8.
10. Rivera JM, Siu SC, Handschumacher MD, Lether JP, Guerro
JL, Vlahakes GJ,
Mitchell JD, Weyman AE, King MEE, Levine RA. Three-dimensional
reconstruction
of ventricular septal defects: validation studies and in vivo
feasibility.
J Am Coll Cardiol 1994;23:201-8.
11. Marx G, Fulton DR, Pandian NG, Vogel M, Cao QL,
Ludomirski A, Delabays A,
Sugeng L, Klas B. Delineation of site, relative size
and dynamic geometry of
atrial septal defects by real-time three-dimensional
echocardiography.
J Am Coll Cardiol 1995;25:482-90.
12. Gopal AS, Keller AM, Shen Z, Sapin PM, Schroeder KM, King
Jr DL,
King DL. Three-dimensional echocardiography: in vitro and in vivo
validation
of left ventricular mass and comparison with conventional
echocardiographic methods. J Am Coll Cardiol 1994;24:504-13.
13. Iwase M, Kondo T, Hasegawa K, Kimura M, Matsuyama H,
Watanabe Y,
Hishida H. Three-dimensional echocardiography by semi-automated
border
detection in assessment of left ventricular volume and ejection fraction:
comparison with magnetic resonance imaging. J Cardiol 1997;30:97-105.
14. Buck T, Hunold P, Wentz KU, Tkalec W, Nesser JM, Erbel R.
Tomographic three-dimensional echocardiographic determination of chamber
size
and systolic function in patients with left ventricular aneurysm.
Circulation
1997;96:286-97.
15. Vogel M, Guberlet M, Dittrich S, Hosten N, Lange PE.
Comparison of transthoracic three-dimensional echocardiography with
magnetic
resonance imaging in the assessment of right ventricular volume and
mass. Heart 1997;78:127-30.
16. Altmann K, Shen Z, Boxt LM, King DL, Gersony WM, Allan
LD, Apfel HD.
Comparison of three-dimensional echocardiographic assessment of
volume,
mass and function in children with functionally single ventricles with
two-dimensional echocardiography and magnetic resonance imaging.
Am J
Cardiol 1997;80:1060-5.
17. Nosir YFM, Lequin MH, Kasprzak JD, Yao J, Stoker J,Roelandt
JRTC.
Measurements and day to day variabilities of left ventricular volumes
and
ejection fraction by three-dimensional echocardiography and comparision
with
magnetic resonance imaging Am J Cardiol
1998;2:209-214.
18. Bruining N, Berlage T, Grunst G, Alkar HJ, Mumm B,
Angelsen B,
Komorowski J, Redel DA, Pinto F, Roelandt JRTC. CardiAssist:
developing a
support platform for 3D ultrasound. In: Computers in cardiology.
Indianapolis:
IEEE Computer Society Press, 1997:p557-60.
19. Vourvouri EC, De Sutter J, Poldermans D, et al.
Experience with an ultrasound stethoscope.J Am Soc Echocardiogr, in
press.
20. Roelandt JRTC. A personal ultrasound imager (ultrasound
stethoscope)
Eur Heart J 2001;in press.
21. Goodkin GM, Spevack DM, Tunick PA, Kronzon I.
How useful
is hand-carried bedside echocardiography in critically ill patients?
J Am
Coll Cardiol 2001;37:2019-22.
22. Rozycki GS, Pchsner G, Schmidt JA, et al.
A prosepective study of
surgeon-performed ultrasound as the primary
adjuvant modality for injured patient
assessment. J Trauma 1995;492-500.
23. Vourvouri EC, Poldermans D, Schinkel AF, Sozzi FB, Bax JJ,
van Urk H,
Roelandt JR. Abdominal aortic aneurysm screening using a
hand-held
ultrasound device. A pilot study.
Eur J Vasc Endovasc Surg 2001;22:352-4.
24. Bruce CJ, Spittell PC, Montgomery SC, et al. Personal
ultrasound imager:
abdominal aortic aneurysm screening. J Am Soc Echocardiogr
2000;13:674-9.
25. Sheps SG, Frohlich ED. Limited echocardiography for
hypertensive left
ventricular hypertrophy. Hypertension 1997;29:560-3.
26. Lahiri A, Galasko GIW, Senior R. Portable
echocardiography – an innovative tool in
the assessment of left ventricular
dysfunction in the community.
Eur. Heart J 2001 (abs supl), iii-vi:706.
27. Kimura BJ, Scott R, Willis CL, DeMaria AN. Accuracy and
cost-effectiveness of single-view echocardiographic screening for suspected
mitral valve prolapse. Am J Med 2000;108:331-3.
Jewel of The Alhambra
ALHAMBRA, Granada, Spain
"A place of perfect beauty. . . Color and light melt and blend together. .
.
|
* Professor of Cardiology, Head, Department of Cardiology, Thoraxcentre
University Hospital Rotterdam, The Netherlands.
Correspondence to: Professor J.R.T.C. Roelandt,
Thoraxcentre University Hospital Rotterdam,
Dijkzigt P.O. Box 2040/Dr. Molewaterplein 40 3000 CA/3015 GD ROTTERDAM The Netherlands
Fax: +31.10.436.2995 Email: roelandt@card.azr.nl
|
|